Table 2.
Patient survey results
| Topic and response categories | Patients, n (%) |
|---|---|
| n = 1598 | |
| Dosing of NER1006 | |
| 2-day pm/am dosing regimen | 1463 (91.6) |
| 1-day am/am dosing regimen (day of colonoscopy) | 135 (8.4) |
| Volume of bowel preparation regimen completed | |
| All | 1392 (87.1) |
| Most | 167 (10.5) |
| At least half | 29 (1.8) |
| Less than half | 10 (0.6) |
| “How easy was it for you to prepare and take [NER1006]?” | |
| Very easy (score, 7–9) | 1216 (76.1) |
| Medium level of difficulty (score, 4–6) | 245 (15.3) |
| Very difficult (score, 1–3) | 137 (8.6) |
| “How important is it to you that [NER1006] can be taken with your choice of clear liquids?” | |
| Very important (score, 7–9) | 1192 (74.6) |
| Medium importance (score, 4–6) | 273 (17.1) |
| Not important (score, 1–3) | 133 (8.3) |
| “Would you be willing to recommend [NER1006] to family/friends?” | |
| Yes | 1027 (64.3) |
| Maybe | 414 (25.9) |
| No | 157 (9.8) |
| “How was your experience with [NER1006] compared to the other bowel cleansing medications(s) you previously used?a | n = 1005 |
| Much better/better | 656 (65.3) |
| About the same | 195 (19.4) |
| Worse/much worse | 154 (15.3) |
aFor the 1005 patients for whom this was not their first colonoscopy, prior bowel cleansing medications were: 4 L PEG (23.5%; any formulation), oral sodium sulfate (17.1%), over-the-counter agent(s) (12.8%), 2 L PEG (11.4%), other (13.0%), or unknown (39.4%). Patients may have selected > 1 prior bowel preparation. PEG: polyethylene glycol. Used with permission from Cash B. and Moncrief MBC, abstract 534. Am J Gastroenterol. 2019; 114:S36 [14]